EQT Logo

Divestments

Aelin Therapeutics

Novel therapeutic modality to induce functional knockdown of a target protein.

Key Facts
Sector

Life Sciences

Country

Belgium

Fund

LSP 5

Entry

2017

Exit

2023

Do You Want to Know More?

We are eager to explore how we can achieve great things together.